MRSA Research Today is a free monthly online journal that collates and summarizes the latest research about MRSA, including details on methicillin-resistant staphylococcus aureus, hospitals, infection, antibiotic resistance, superbugs.

Volume 7 (2010), Issue 1 (January)

1. What lessons have been learnt from animal models of MRSA in the lung?
   Eur Respir J, 35(1): 198-201. [Abstract] [Full-text]
2. Isolation Precautions for Methicillin-Resistant Staphylococcus aureus: Electronic Surveillance to Monitor Adherence.
   Am J Crit Care, 19(1): 16-26; quiz 27. [Abstract] [Full-text]
3. Streptococcus pneumoniae coinfection is correlated with the severity of H1N1 pandemic influenza.
   PLoS One, 4(12): e8540. [Abstract] [Full-text]
4. Antimicrobial-resistant pathogens in animals and man: prescribing, practices and policies.
   J Antimicrob Chemother, 65: i3-17. [Abstract] [Full-text]
5. Close cooperation between infectious disease physicians and attending physicians results in better outcomes for patients with Staphylococcus aureus bacteraemia.
   Clin Microbiol Infect. [Abstract] [Full-text]
6. Real-Time PCR Assays compared to Culture-Based Approaches for Identification of Aerobic Bacteria in Chronic Wounds.
   Clin Microbiol Infect. [Abstract] [Full-text]
7. Dermatologic infections in cancer patients treated with epidermal growth factor receptor inhibitor therapy.
   J Natl Cancer Inst, 102(1): 47-53. [Abstract] [Full-text]
8. Tracheobronchitis Caused by Methicillin-Resistant Staphylococcus aureus as a Cause of Chronic Wheezing in a Non-Ventilated Adult Patient with Tracheobronchomalacia.
   Respiration. [Abstract] [Full-text]
9. Cytokine profile during the clinical course of toxic shock syndrome.
   Clin Exp Dermatol, 34(8): e632-5. [Abstract] [Full-text]
10. Transmission of methicillin-resistant Staphylococcus aureus to household contacts.
    J Clin Microbiol, 48(1): 202-7. [Abstract] [Full-text]
11. Familial furunculosis associated with community-acquired leukocidin-positive methicillin-susceptible Staphylococcus aureus ST152.
    J Clin Microbiol, 48(1): 329-32. [Abstract] [Full-text]
12. Invasive infection caused by a community-associated methicillin-resistant Staphylococcus aureus strain not carrying Panton-Valentine leukocidin in South Korea.
    J Clin Microbiol, 48(1): 311-3. [Abstract] [Full-text]
13. Nasal colonization of and clonal transmission of methicillin-susceptible Staphylococcus aureus among Chinese military volunteers.
    J Clin Microbiol, 48(1): 64-9. [Abstract] [Full-text]
14. Spectra MRSA, a new chromogenic agar medium to screen for methicillin-resistant Staphylococcus aureus.
    J Clin Microbiol, 48(1): 215-9. [Abstract] [Full-text]
15. Clinical and economic impact of methicillin-resistant Staphylococcus aureus colonization or infection on neonates in intensive care units.
    Infect Control Hosp Epidemiol, 31(2): 177-82. [Abstract] [Full-text]
16. Hospital-acquired Staphylococcus aureus infections at Texas Children's Hospital, 2001-2007.
    Infect Control Hosp Epidemiol, 31(2): 183-90. [Abstract] [Full-text]
17. Cloning, expression and crystallization of dihydrodipicolinate reductase from methicillin-resistant Staphylococcus aureus.
    Acta Crystallogr Sect F Struct Biol Cryst Commun, 66: 57-60. [Abstract] [Full-text]
18. High potency and broad-spectrum antimicrobial peptides synthesized via ring-opening polymerization of alpha-aminoacid-N-carboxyanhydrides.
    Biomacromolecules, 11(1): 60-7. [Abstract] [Full-text]
19. Population structure of a hybrid clonal group of methicillin-resistant Staphylococcus aureus, ST239-MRSA-III.
    PLoS One, 5(1): e8582. [Abstract] [Full-text]
20. Novel L-amino acid oxidase with antibacterial activity against methicillin-resistant Staphylococcus aureus isolated from epidermal mucus of the flounder Platichthys stellatus.
    FEBS J, 277(2): 453-65. [Abstract] [Full-text]
21. Rose Bengal-decorated silica nanoparticles as photosensitizers for inactivation of gram-positive bacteria.
    Nanotechnology, 21(6): 065102. [Abstract] [Full-text]
22. Rifampin combination therapy for nonmycobacterial infections.
    Clin Microbiol Rev, 23(1): 14-34. [Abstract] [Full-text]
23. Challenges in anti-infective development in the era of bad bugs, no drugs: a regulatory perspective using the example of bloodstream infection as an indication.
    Clin Infect Dis, 50: S4-9. [Abstract] [Full-text]
24. Evaluation of selection media for the detection of borderline MRSA.
    J Infect Chemother. [Abstract] [Full-text]
25. Staphylococcus aureus panton-valentine leukocidin is a very potent cytotoxic factor for human neutrophils.
    PLoS Pathog, 6(1): e1000715. [Abstract] [Full-text]
26. Patients' experiences of being infected with MRSA at a hospital and subsequently source isolated.
    Scand J Caring Sci. [Abstract] [Full-text]
27. Evaluation of the efficacy of electrochemically activated solutions against nosocomial pathogens and bacterial endospores.
    Lett Appl Microbiol. [Abstract] [Full-text]
28. Staphylococcus aureus Bloodstream Infections in Older Adults: Clinical Outcomes and Risk Factors for In-Hospital Mortality.
    J Am Geriatr Soc. [Abstract] [Full-text]
29. Efficacy and safety of linezolid in methicillin-resistant Staphylococcus aureus (MRSA) complicated skin and soft tissue infection (cSSTI): a meta-analysis.
    Curr Med Res Opin, 26(2): 407-21. [Abstract] [Full-text]
30. Central line-associated bloodstream infection: is the hospital epidemiology of methicillin-resistant Staphylococcus aureus relevant?
    J Infect Chemother. [Abstract] [Full-text]
31. Bacteremia in Stevens-Johnson syndrome and toxic epidermal necrolysis: epidemiology, risk factors, and predictive value of skin cultures.
    Medicine (Baltimore), 89(1): 28-36. [Abstract] [Full-text]
32. Genome sequence of a recently emerged, highly transmissible, multi-antibiotic- and antiseptic-resistant variant of methicillin-resistant Staphylococcus aureus, sequence type 239 (TW).
    J Bacteriol, 192(3): 888-92. [Abstract] [Full-text]
33. Synthesis and antistaphylococcal activity of N-substituted-1H-benzimidazole-sulphonamides.
    Arch Pharm (Weinheim), 343(1): 31-9. [Abstract] [Full-text]
34. Rapid, automated epidemiological typing of methicillin-resistant Staphylococcus aureus.
    J Microbiol Methods, 80(1): 109-11. [Abstract] [Full-text]
35. Universal screening for meticillin-resistant Staphylococcus aureus: interim results from the NHS Scotland pathfinder project.
    J Hosp Infect, 74(1): 35-41. [Abstract] [Full-text]
36. Geographic distribution of Staphylococcus aureus causing invasive infections in Europe: a molecular-epidemiological analysis.
    PLoS Med, 7(1): e1000215. [Abstract] [Full-text]
37. Photodynamic therapy for methicillin-resistant Staphylococcus aureus infection in a mouse skin abrasion model.
    Lasers Surg Med, 42(1): 38-44. [Abstract] [Full-text]
38. Genetic analysis of high-level mupirocin resistance in the ST80 clone of community-associated meticillin-resistant Staphylococcus aureus.
    J Med Microbiol, 59: 193-9. [Abstract] [Full-text]
39. Atypical presentation of an apical pseudoaneurysm in a patient on prolonged left ventricular mechanical support.
    Interact Cardiovasc Thorac Surg, 10(2): 350-1. [Abstract] [Full-text]
40. Fosfomycin: an old, new friend?
    Eur J Clin Microbiol Infect Dis, 29(2): 127-42. [Abstract] [Full-text]
41. Characterisation of MRSA from Malta and the description of a Maltese epidemic MRSA strain.
    Eur J Clin Microbiol Infect Dis, 29(2): 163-70. [Abstract] [Full-text]
42. Empyema necessitatis revisited.
    Eur J Dermatol, 20(1): 115-9. [Abstract] [Full-text]
43. Short term micro-evolution and PCR-detection of methicillin-resistant and -susceptible Staphylococcus aureus sequence type 398.
    Eur J Clin Microbiol Infect Dis, 29(1): 119-22. [Abstract] [Full-text]
44. First report on methicillin-resistant Staphylococcus aureus of Spa type T037, Sequence Type 239, SCCmec type III/IIIA in Malaysia.
    Eur J Clin Microbiol Infect Dis, 29(1): 115-7. [Abstract] [Full-text]
45. Antimicrobial activity of small beta-peptidomimetics based on the pharmacophore model of short cationic antimicrobial peptides.
    J Med Chem, 53(2): 595-606. [Abstract] [Full-text]
46. Functional analysis of a putative holin-like peptide-coding gene in the genome of Bacillus licheniformis AnBa9.
    Arch Microbiol, 192(1): 51-6. [Abstract] [Full-text]
47. Risk factors for treatment failure in orthopedic device-related methicillin-resistant Staphylococcus aureus infection.
    Eur J Clin Microbiol Infect Dis, 29(2): 171-80. [Abstract] [Full-text]
48. Subinhibitory concentrations of licochalcone A decrease alpha-toxin production in both methicillin-sensitive and methicillin-resistant Staphylococcus aureus isolates.
    Lett Appl Microbiol, 50(2): 223-9. [Abstract] [Full-text]
49. Community-acquired pneumonia due to pandemic A(H1N1)2009 influenzavirus and methicillin resistant Staphylococcus aureus co-infection.
    PLoS One, 5(1): e8705. [Abstract] [Full-text]
50. Evaluation and comparison of tests to detect methicillin resistant S. aureus.
    Indian J Pathol Microbiol, 53(1): 79-82. [Abstract] [Full-text]
51. Staphylococcus aureus is the most common identified cause of cellulitis: a systematic review.
    Epidemiol Infect, 138(3): 313-7. [Abstract] [Full-text]
52. In vitro antimicrobial activity of silver-processed catheters for neurosurgery.
    J Antimicrob Chemother, 65(2): 258-65. [Abstract] [Full-text]
53. A survey of attitudes towards methicillin-resistant Staphylococcus aureus bacteraemias amongst United Kingdom microbiologists.
    J Antimicrob Chemother, 65(2): 347-9. [Abstract] [Full-text]
54. Evolution of MRSA during hospital transmission and intercontinental spread.
    Science, 327(5964): 469-74. [Abstract] [Full-text]
55. Lack of bactericidal antagonism or synergism in vitro between oxacillin and vancomycin against methicillin-susceptible strains of Staphylococcus aureus.
    Antimicrob Agents Chemother, 54(2): 773-7. [Abstract] [Full-text]
56. In vivo assessment of the antimicrobial activity of a calcium-deficient apatite vancomycin drug delivery system in a methicillin-resistant Staphylococcus aureus rabbit osteomyelitis experimental model.
    Antimicrob Agents Chemother, 54(2): 950-2. [Abstract] [Full-text]
57. Interaction of ceftobiprole with the low-affinity PBP 5 of Enterococcus faecium.
    Antimicrob Agents Chemother, 54(2): 953-5. [Abstract] [Full-text]
58. Ceftobiprole is superior to vancomycin, daptomycin, and linezolid for treatment of experimental endocarditis in rabbits caused by methicillin-resistant Staphylococcus aureus.
    Antimicrob Agents Chemother, 54(2): 610-3. [Abstract] [Full-text]
59. Recombination between ccrC genes in a type V (5C2&5) staphylococcal cassette chromosome mec (SCCmec) of Staphylococcus aureus ST398 leads to conversion from methicillin resistance to methicillin susceptibility in vivo.
    Antimicrob Agents Chemother, 54(2): 783-91. [Abstract] [Full-text]
60. Detection and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates in Canada: results from the Canadian Nosocomial Infection Surveillance Program, 1995-2006.
    Antimicrob Agents Chemother, 54(2): 945-9. [Abstract] [Full-text]
61. Population pharmacokinetic analysis of vancomycin using serum cystatin C as a marker of renal function.
    Antimicrob Agents Chemother, 54(2): 778-82. [Abstract] [Full-text]
62. Effects of ceftobiprole and oxacillin on mecA expression in methicillin-resistant Staphylococcus aureus clinical isolates.
    Antimicrob Agents Chemother, 54(2): 956-9. [Abstract] [Full-text]
63. Identification of a plasmid-borne resistance gene cluster comprising the resistance genes erm(T), dfrK, and tet(L) in a porcine methicillin-resistant Staphylococcus aureus ST398 strain.
    Antimicrob Agents Chemother, 54(2): 915-8. [Abstract] [Full-text]
64. Distribution of methicillin-resistant Staphylococcus aureus in a low-prevalence area.
    FEMS Immunol Med Microbiol. [Abstract] [Full-text]
65. Antibacterial properties of nanostructured silver titanate thin films formed on a titanium plate.
    J Biomed Mater Res A, 92(3): 1171-80. [Abstract] [Full-text]
66. Structure and antibacterial activity of brominated diterpenes from the red alga Sphaerococcus coronopifolius.
    Chem Biodivers, 7(1): 186-95. [Abstract] [Full-text]
67. Staphylococcus aureus endophthalmitis: antibiotic susceptibilities, methicillin resistance, and clinical outcomes.
    Am J Ophthalmol, 149(2): 278-283.e1. [Abstract] [Full-text]
68. Vancomycin-associated nephrotoxicity: grave concern or death by character assassination?
    Am J Med, 123(2): 182.e1-7. [Abstract] [Full-text]
69. In vivo antibacterial and silver-releasing properties of novel thermal sprayed silver-containing hydroxyapatite coating.
    J Biomed Mater Res B Appl Biomater, 92(2): 386-9. [Abstract] [Full-text]
70. High heterogeneity within methicillin-resistant Staphylococcus aureus ST398 isolates, defined by Cfr9I macrorestriction-pulsed-field gel electrophoresis profiles and spa and SCCmec types.
    Appl Environ Microbiol, 76(3): 652-8. [Abstract] [Full-text]
71. Production of the Bsa lantibiotic by community-acquired Staphylococcus aureus strains.
    J Bacteriol, 192(4): 1131-42. [Abstract] [Full-text]
72. Gas chromatographic-mass spectrometric analysis of volatiles obtained by four different techniques from Salvia rosifolia Sm., and evaluation for biological activity.
    J Chromatogr A, 1217(5): 741-8. [Abstract] [Full-text]
73. Cradle-to-gate life cycle inventory of vancomycin hydrochloride.
    Sci Total Environ, 408(6): 1331-7. [Abstract] [Full-text]
74. Secreted virulence factor comparison between methicillin-resistant and methicillin-sensitive Staphylococcus aureus, and its relevance to atopic dermatitis.
    J Allergy Clin Immunol, 125(1): 39-49. [Abstract] [Full-text]
75. Diagnosis and management of community-associated MRSA infections in children.
    Expert Rev Anti Infect Ther, 8(2): 183-95. [Abstract] [Full-text]
76. Management of acute hematogenous osteomyelitis in children.
    Expert Rev Anti Infect Ther, 8(2): 175-81. [Abstract] [Full-text]
77. An integrated approach to methicillin-resistant Staphylococcus aureus control in a rural, regional-referral healthcare setting.
    Infect Control Hosp Epidemiol, 31(3): 269-75. [Abstract] [Full-text]

© 2004-2012 MRSA Research Today. All Rights Reserved.